
The EMA has announced its intention to introduce revised guidelines concerning the use of medicines in first in-human clinical trials …

In what will be regarded as a watershed moment, scientists working at Oregon Health and Science University have used CRISPR …

GSK has created a whole new role to push the company to strengthen its digital, data and analytics strategy, with …

It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …

Essentra, a manufacturer of packaging for the pharmaceutical and retail industry, has revealed that it is undergoing a consultation process …

The long-awaited results for AstraZeneca’s Mystic trial have been revealed and, in a shocking setback for the company, it was …

If you’ve ever taken a course of antibiotics then you will be familiar with the piece of advice that is …

Amongst other announcements at its second quarter statement, GSK’s CEO, Emma Walmsley, gave a hint towards the British-based company’s desires …

Sanofi Pasteur Korea has announced that Baptiste de Clarens will be the new General Manager of the unit, after the …

New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London, have developed a gene therapy …

It has been announced that Celgene has agreed to settle a case after a whistle-blower launched a lawsuit against the …

Data released by NHS Digital rings a very worn bell regarding levels of staff employed and recruited the NHS, as …

Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …

The US faces an ongoing crisis in opioid dependency, and FDA Commissioner Scott Gottlieb is prepared to employ unusual tactics …

Cardinal Health, one of the largest drug distributors in the US, is looking to sell on its network in China, …